v3.26.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 102,448,764 102,573,283
Common stock, shares outstanding (in shares) 102,448,764 102,573,283
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 200,000,000 200,000,000
Preferred stock, shares issued (in shares) 2,600,000 6,800,000
Preferred stock, shares outstanding (in shares) 2,600,000 6,800,000
Accounts receivable, net [1] $ 155,638 $ 209,907
Other current assets [2] 470,130 408,364
Equity Method Investee    
Accounts receivable, net 10,951 47,294
Other current assets $ 3,086 $ 20,681
[1] Includes accounts receivable from the SCI Partnerships of $10,951 as of September 30, 2026 (December 31, 2025 - $47,294).
[2] Includes receivables from the SCI Partnerships of $3,086 as of September 30, 2026 (December 31, 2025 - $20,681).